186 related articles for article (PubMed ID: 2269381)
21. Low-dose cyclosporine A in the treatment of disabling morphea.
Peter RU; Ruzicka T; Eckert F
Arch Dermatol; 1991 Sep; 127(9):1420-1. PubMed ID: 1892419
[No Abstract] [Full Text] [Related]
22. Guttate morphea in a scleroderma spectrum disorder patient with anticentromere antibody.
Yamanaka M; Ishikawa O
Eur J Dermatol; 2009; 19(6):630-1. PubMed ID: 19596641
[No Abstract] [Full Text] [Related]
23. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous malignant melanomas occurring under cyclosporin A therapy: a report of two cases.
Mérot Y; Miescher PA; Balsiger F; Magnenat P; Frenk E
Br J Dermatol; 1990 Aug; 123(2):237-9. PubMed ID: 2400725
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A in systemic sclerosis.
Zachariae H; Zachariae E
Br J Dermatol; 1987 May; 116(5):741-2. PubMed ID: 3593641
[No Abstract] [Full Text] [Related]
26. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
27. Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
Mizutani H; Yoshida T; Nouchi N; Hamanaka H; Shimizu M
J Dermatol; 1999 Jan; 26(1):11-7. PubMed ID: 10063206
[TBL] [Abstract][Full Text] [Related]
28. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
[TBL] [Abstract][Full Text] [Related]
29. Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases.
Denton CP; Sweny P; Abdulla A; Black CM
Br J Rheumatol; 1994 Jan; 33(1):90-2. PubMed ID: 8162467
[TBL] [Abstract][Full Text] [Related]
30. Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy.
Fritzler MJ; Hart DA
Arthritis Rheum; 1990 Feb; 33(2):274-6. PubMed ID: 2106327
[TBL] [Abstract][Full Text] [Related]
31. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
[TBL] [Abstract][Full Text] [Related]
32. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
[TBL] [Abstract][Full Text] [Related]
33. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
[TBL] [Abstract][Full Text] [Related]
34. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
Distler O; Cozzio A
Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
[TBL] [Abstract][Full Text] [Related]
35. Photochemotherapy for systemic and localized scleroderma.
De Rie MA; Bos JD
J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
[No Abstract] [Full Text] [Related]
36. Scleroderma Renal Crisis Complicating Male-to-Female Transgender Hormonal Therapy in a Patient With Long-Standing and Stable Limited Cutaneous Systemic Sclerosis.
Arneson LC; Varga J
J Clin Rheumatol; 2021 Dec; 27(8S):S355-S356. PubMed ID: 32956156
[No Abstract] [Full Text] [Related]
37. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
Daróczy J; Gyöngyvér S
Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
[No Abstract] [Full Text] [Related]
38. RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.
Watson KD; Makol A
Rheumatology (Oxford); 2017 Nov; 56(11):1856. PubMed ID: 29088451
[No Abstract] [Full Text] [Related]
39. Case of localized scleroderma successfully treated with bath psoralen and ultraviolet A therapy.
Uchiyama M; Okubo Y; Kawashima H; Yamamoto K; Mitsuhashi Y; Tsuboi R
J Dermatol; 2010 Jan; 37(1):75-80. PubMed ID: 20175842
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes in systemic scleroderma and generalized morphea.
O'Loughlin S; Tappeiner G; Jordon RE
Dermatologica; 1980; 160(1):25-30. PubMed ID: 7351267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
